Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial

NCT00500279 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

900

Enrollment

OTHER

Sponsor class

Conditions

Angioplasty, Transluminal, Percutaneous Coronary
Coronary Restenosis

Interventions

DRUG: Celecoxib

Sponsor

Seoul National University Hospital